Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.
about
Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of HemoglobinThe involvement of cation leaks in the storage lesion of red blood cells.Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.Metabolomics of ADSOL (AS-1) red blood cell storageEnvironmental tobacco smoke and airway obstruction in children with sickle cell anemia.Metabolomics in transfusion medicine.Erythrocyte Purinergic Signaling Components Underlie Hypoxia Adaptation.Proteomic analysis of red blood cells and the potential for the clinic: what have we learned so far?New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?Oxidative pathways in the sickle cell and beyond.Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia.Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.Ebselen exhibits glycation-inhibiting properties and protects against osmotic fragility of human erythrocytes in vitro.The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study.The effect of xanthine oxidase and hypoxanthine on the permeability of red cells from patients with sickle cell anemia.Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease
P2860
Q27727697-4049C56E-0DC5-49CA-BA66-8D15D1E57364Q33766511-8F5D4C84-5442-4EE7-B86E-8B8E1284FBC2Q34330046-2358BE10-3FF0-4881-864D-8E60BCEDA9E0Q35122576-C91B2246-FB3C-41A9-BBB5-42CBFFB5977CQ37209578-8604482D-88A8-41E8-B789-12F11DA201DEQ38667980-90192D50-60A2-4D91-992D-02B06031C7DEQ38749962-C9019A73-88BC-4D43-8DA0-AB9C3F4FFCE2Q38761406-7C9FFD3E-4211-4C5E-B00C-7A90DD317A70Q38948912-83DC3DEF-FBF4-4495-AB55-E229871F4371Q39336717-FACFF4A8-E7EF-4350-B22B-D769ACE69FBFQ43078942-D72E1672-4FDF-4B26-9C21-DC407F73F7C3Q45066332-DA909999-152F-4F3A-A6F4-759EDF84A1A3Q45072663-6B590CAE-157D-407F-9476-5DA93168293DQ46940209-73D805DF-D556-42FA-884D-D13C1609B860Q47358564-677DE8F9-C472-410C-8BFF-1CFA2621D886Q53441683-B8FA6114-1BD2-4552-AC15-79F6BF6890C0Q58790209-72C0E3F1-9362-422F-AC41-B3F283ABD626
P2860
Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@ast
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@en
type
label
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@ast
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@en
prefLabel
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@ast
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@en
P2093
P2860
P1433
P1476
Sickle hemoglobin disturbs nor ...... sis, and antioxidant capacity.
@en
P2093
Andre d'Avignon
Dylan McLaughlin
Jerlinda G C Ross
Lindsey B Gibbons
Malcolm Debaun
Michael R DeBaun
Mojibade N Hassan
Sherraine Griffin
Tara Neumayr
Vered Gazit
P2860
P304
P356
10.1182/BLOOD-2012-02-414037
P407
P577
2013-01-07T00:00:00Z